Radioimmunodetection of malignant solid tumours

References

• Kairemo K JA. Radioimmunoimaging in clinical oncology: possibilities and limitations. Medical Faculty, University of Helsinki. 1993; 142, Academic dissertation
   Google Scholar
• Baum R P., Lorenz M, Hör G. Radioimmunszinti-graphie bei kolorektalen Karzinomen-Stellenwert in der Rezidivdiagnostik nach 2 Jahren klinischer Erfahrung. Der Nuklearmediziner 1987; 3: 219–34
   Google Scholar
• Abdel-Nabi H H., Schwartz A N., Goldfogel G, et al. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohisto-chemical findings. Radiology 1988; 166: 747–52
   PubMed Web of Science ®Google Scholar
• Goldenberg D M., Goldenberg H, Sharkey R M., et al. Imaging of colorectal carcinoma with radiolabeled antibodies. Semin Nucl Med 1989; 19: 262–81
   PubMed Web of Science ®Google Scholar
• Lind P, Lechner P, Arian-Schad K, et al. Anti-carcinoembryonic antigen immunoscintigraphy (Technetium 99m-monoclonal antibody BW 431/ 26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991; 32: 1319–25
   PubMed Web of Science ®Google Scholar
• Larson S M., Carrasquillo J A., Krohn K A., et al. Localization of p97 specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 1983; 72: 2101–14
   PubMed Web of Science ®Google Scholar
• Siccardi A G., Buraggi G L., Natali P G., et al. European multicentre study of melanoma immunoscintigraphy by means of 99mTc-labeled monoclonal antibody fragments. Eur J Nucl Med 1990; 16: 317–23
   PubMedGoogle Scholar
• Eary J F., Schroff R W., Abrams P G., et al. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. J Nucl Med 1989; 30: 25–32
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Pyrhönen S. Radioimmunodetection and radioimmunotherapy of malignant melanoma. A review. Acta Oncol 1993; 32: 717–22
   PubMed Web of Science ®Google Scholar
• Vihko P, Kontturi M, Lukkarinen O, et al. Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma. Prostate 1987; 11: 51–7
   PubMed Web of Science ®Google Scholar
• Babaian R J., Lamki L M. Radioimmunoscintigraphy of prostate cancer. Semin Nucl Med 1989; 19: 309–21
   PubMed Web of Science ®Google Scholar
• Kairemo K JA, Rannikko S, Nordling S, Ellmen J, Salo J O., Alfthan O S. Radioimmunodetection of prostate cancer using 111in-labeled anti-prostatic acid monoclonal antibody. Antibody Immuno-conj Radiopharm 1990; 3: 46
   Google Scholar
• Leroy M, Teillac P, Rain J D., Saccavini J C., LeDuc A, Najean Y. Radioimmunodetection of lymph node invasion in prostatic cancer The use of iodine 123 (123I-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo. Cancer 1989; 64: 1–5
   PubMed Web of Science ®Google Scholar
• Abdel-Nabi H H., Wright G L., Gulfo J V., et al. Monoclonal antibodies and radioimmuno-conjugates in the diagnosis and treatment of prostate cancer. Semin Urol 1992; 10: 45–54
   PubMedGoogle Scholar
• Coakham H B., Garson J A., Brownell B, Kemshead J T. Diagnosis of cerebral neoplasms using monoclonal antibodies. Prog exp Tumor Res 1985; 29: 57–77
   PubMed Web of Science ®Google Scholar
• Zalutsky M R., Moseley R P., Coakham H B., Coleman R E., Bigner D D. Pharmacokinetics and tumor localization of 131I -labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res 1989; 49: 2807–13
   PubMed Web of Science ®Google Scholar
• Kalofonos H P., Pawlikowska T W., Hemingway A, et al. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J Nucl Med 1989; 30: 1636–45
   PubMed Web of Science ®Google Scholar
• Dillman R O., Shawler D L., Dillman J B., Royston I. Therapy of chronic lymphocytic leukemia and cutaneous T cell lymphoma with T101 monoclonal antibody. J Clin Oncol 1984; 2: 881–91
   PubMed Web of Science ®Google Scholar
• Grignani F, Martelli M F., Mason D Y. Monoclonal antibodies in haematopathology. Raven Press, New York 1986; Vol. 26: 383, Serono Symposia Publications from Raven Press
   Google Scholar
• Zimmer A M., Rosen S M., Spies S M., Goldman-Leiken R, Kazikiewicz J M., Silverstein E A., Kaplan E H. Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis. J Nucl Med 1988; 29: 174–80
   PubMed Web of Science ®Google Scholar
• Eary J F., Press O W., Badger C C., et al. Imaging and treatment of B-cell lymphoma. J Nucl Med 1990; 31: 1257–68
   PubMed Web of Science ®Google Scholar
• Chan S YT, Evan G I., Ritson A, Watson J, Wraight P, Sikora K. Localisation of lung cancer by a radiolabeled monoclonal antibody against the c-myc oncogene product. Br J Cancer 1986; 54: 761–9
   PubMed Web of Science ®Google Scholar
• Goldenberg D M., Larson S M. Radioimmunodetection in cancer identification. J Nucl Med 1992; 33: 803–14
   PubMed Web of Science ®Google Scholar
• Sikora K, Alderson T, Finan P, et al. The selection of monoclonal antibodies for tumour localization in patients with colorectal carcinoma. Med Oncol Tumor Pharmacother 1984; 1: 63–71
   PubMedGoogle Scholar
• Tilgen W, Matzku S, Kaufmann, et al. Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay. Arch Dermatol Res 1987; 279: S116–26
   Web of Science ®Google Scholar
• Bhargava K K., Acharya S A. Labeling of monoclonal antibodies with radionuclides. Semin Nucl Med 1989; 19: 187–201
   PubMed Web of Science ®Google Scholar
• DeNardo S J., Peng J-S B., DeNardo G L., Mills S L., Epstein A L. Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development. Nucl Med Biol 1986; 13: 303–10
   Web of Science ®Google Scholar
• Pant K D., Zamora P O., Sass K S., et al. A comparison of monoclonal antibodies against distinct colon tumor-associated antigens in immunohisto-chemistry and in tumor localization. Nucl Med Biol 1987; 14: 81–9
   Web of Science ®Google Scholar
• Horstmeier U, Klapdor R, Bahlo M, Montz R. Immunoscintigraphy with combinations of various monoclonal antibodies- studies on xenografts of human gastrointestinal carcinomas. Nucl Med 1988; 27: 46–50
   Google Scholar
• Goodwin D A., Meares C F., McCall M J., McTigue M, Chaovapong W. Pretargeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 1988; 29: 226–34
   PubMed Web of Science ®Google Scholar
• Goldenberg D M., Sharkey R M., Ford E. Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies. J Nucl Med 1987; 28: 1604–10
   PubMed Web of Science ®Google Scholar
• Traub U C., DeJager R, Primus F J., Losman M, Goldenberg D M. Antiidiotype antibodies in cancer patients receiving monoclonal antibody carcinoembryonic antigen. Cancer Res 1988; 48: 4002–6
   PubMed Web of Science ®Google Scholar
• Schroff R W., Morgan A C., Woodhouse C S., et al. Monoclonal antibody therapy in malignant melanoma: factors effecting in vivo localization. J Biol Resp Modif 1987; 6: 457–72
   PubMedGoogle Scholar
• Fairweather D S., Bradwell A R., et al. Improved tumour localisation using indium-111 labelled antibodies. Br Med J 1983; 287: 167–70
   PubMed Web of Science ®Google Scholar
• Buraggi G L., Turrin A, Cascinelli N, . Immunoscintigraphy with anti-melanoma monoclonal antibodies. Immunoscintigraphy, L Donato, K E. Britton, et al. Gordon & Breach Science Publisher, London 1985; 215–54
   Google Scholar
• Bischof-Delaloye A, Delaloye B, Buchegger F, et al. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. J Nucl Med 1989; 30: 1646–56
   PubMed Web of Science ®Google Scholar
• Baum R P., Hertel A, Lorenz M, Schwarz A, Encke A, Hör G. 99mTc-labelled anti-CEA monoclonal antibody for tumor immunoscintigraphy: first clinical results. Nucl Med Commun 1989; 10: 345–52
   PubMed Web of Science ®Google Scholar
• Bares R, Fassa J, Truong S, Buell U, Schumpelick V. Radioimmunoscintigraphy with 111in labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabeling, antibody kinetics and distribution, findings in tumour and non-tumour patients. Nucl Med Commun 1989; 10: 627–41
   PubMed Web of Science ®Google Scholar
• Granowska M, Britton K E. Radiolabelled monoclonal antibodies in oncology II. Clinical applications in diagnosis. Nucl Med Commun 1991; 12: 83–98
   PubMed Web of Science ®Google Scholar
• Muxi A, Sola M, Bassa P, et al. Radioimmuno-detection of coleractal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26). Nucl Med Commun 1992; 13: 261–70
   PubMedGoogle Scholar
• Goldenberg D M. Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies. Am J Gastroenteral 1991; 86: 1392–403
   PubMed Web of Science ®Google Scholar
• Chetanneau A, Lehur P A., Ripoche D, et al. Histological correlation of 17 prospective immuno-scintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-CEA and(or) CA 19–9 monoclonal antibodies. Eur J Nucl Med 1989; 15: 302–6
   PubMedGoogle Scholar
• Riva P, Moscatelli G, Paganelli G, Benini S, Siccardi A. Antibody-guided diagnosis: An Italian experience on CEA-expressing tumours. Int J Cancer (Suppl) 1988; 2: 114–20
   Google Scholar
• Yokoyama K, Carrasquillo J A., Chang A E., et al. Differences in biodistribution of indium-111- and iodine-131-labeled monoclonal antibodies in patients with colorectal cancer. J Nucl Med 1989; 30: 320–7
   PubMed Web of Science ®Google Scholar
• Thor A D., Edgerton S M. Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications. Semin Nucl Med 1989; 19: 295–308
   PubMed Web of Science ®Google Scholar
• Rainsbury R M., Ott R J., Westwood J H., et al. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-Ill. Lancet 1983; II: 934–8
   Google Scholar
• Kalofonos H P., Sackier J M., Hatzistulianou M, et al. Kinetics, quantitative analysis and radio-immunolocalization using indium-111 -HMFG1 monoclonal antibody in patients with breast cancer. Br J Cancer 1989; 59: 939–42
   PubMed Web of Science ®Google Scholar
• Major P P., Dion A S., Williams C J., Mattes M J., Wang T, Rosenthall L. Breast tumor radio-immunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen. Cancer Res 1990; 50: 927S–31S
   Google Scholar
• Lamki L M., Buzdar A U., Singletary S E., et al. Indium-111-labeled monoclonal antibody in the detection and staging of breast cancer: a phase I study. J Nucl Med 1991; 32: 1326–32
   PubMed Web of Science ®Google Scholar
• DeNardo S J., Warhoe K A., O'Grady L F., et al. Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibody. Int J Biol Markers 1991; 6: 221–30
   PubMedGoogle Scholar
• Johnson T K., Gonzalez R, Kasliwal R K., et al. Distribution of a breast-directed 1–131-labeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy. Radiology 1992; 182: 107–14
   PubMed Web of Science ®Google Scholar
• Sterns E E., Cochran A J. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast. Surg Gynecol Obstet 1989; 169: 81–98
   PubMedGoogle Scholar
• Bakir M A., Eccles S A., Babich J W., et al. c-erbB2 protein overexpression in breast cancer as a target for PET using iodine- 124-labeled monoclonal antibodies. J Nucl Med 1992; 33: 2154–60
   PubMed Web of Science ®Google Scholar
• De Santes K, Slamon D, Anderson S K., et al. Radiolabeled antibody targeting of the HER-2/ neu oncoprotein. Cancer Res 1992; 52: 1916–23
   PubMed Web of Science ®Google Scholar
• Mandeville R, Pateisky N, Philipp K, Kubista E, Dumas F, Grouix B. Immunolymphscintigraphy of axillary lymph node metastases in breast cancer using monoclonal antibodies: first clinical findings. Anticancer Res 1986; 6: 1257–64
   PubMed Web of Science ®Google Scholar
• Tjandra J J., Russell I S., Collins J P., et al. Immunolymphoscintigraphy for the detection of lymph node metastase from breast cancer. Cancer Res 1989; 49: 1600–8
   PubMed Web of Science ®Google Scholar
• Kairemo K JA. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res. 1990; 50: 9492–54
   Google Scholar
• Lind P, Smola P, Lechner P, et al. The immuno-scintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Int J Cancer 1991; 47: 865–9
   PubMed Web of Science ®Google Scholar
• Kenemans P, Yedema C A., Hilgers J HM, et al. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens. Eur J Obstet Gynecol Reprod Biol 1988; 29: 207–18
   PubMed Web of Science ®Google Scholar
• Lloyd K O. Ovarian tumor antigens: Targets for diagnosis, monitoring and therapy. Multimodal treatment of ovarian cancer, P F. Conte. Raven Press, New York 1989; 47–54
   Google Scholar
• Granowska M, Britton K E., Shepherd J H., et al. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol 1986; 4: 730–6
   PubMed Web of Science ®Google Scholar
• Epenetos A A., Carr D, Johnson P M., Bodmer W F., Lavender J P. Antibody-guided radiolocalization of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Br J Radiol 1986; 59: 117–25
   PubMed Web of Science ®Google Scholar
• Davies J O., Davies E R., Howe K, et al. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer. J Royal Soc Med 1985; 78: 899–905
   PubMed Web of Science ®Google Scholar
• Powell M C., Perkins A C., Pimm M V., et al. Diagnostic imaging of gynecologic tumors with the monoclonal antibody 79II/36. Am J Obstet Gynecol 1987; 157: 28–34
   PubMed Web of Science ®Google Scholar
• Epenetos A A., Snook D, Hooker G, et al. Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in the detection of neoplasms of testis, ovary and cervix. Lancet 1985; II: 350–3
   Google Scholar
• Barzen G, Mayr A C., Langer M, et al. Radio-immunoscintigraphy of ovarian cancer with 131-iodine labeled OC- 125 antibody fragments. Eur J Nucl Med 1989; 15: 42–8
   PubMedGoogle Scholar
• Chatal J-F, Fumoleau P, Saccavini J-C, et al. Immunoscintigraphy of recurrences of gynecologic carcinomas. J Nucl Med 1987; 28: 1807–19
   PubMed Web of Science ®Google Scholar
• Smith F W., Cherryman G R., Bayliss A P., et al. A comparative study of ultrasound imaging, x-ray computerized tomography and low field MRI diagnosis of ovarian malignancy. Magnetic Resonance Imaging 1988; 6: 225–7
   PubMed Web of Science ®Google Scholar
• Lehtovirta P, Kairemo K JA, Liewendahl K, Seppälä M. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. Cancer Res 1990; 50: 937s–40s
   Web of Science ®Google Scholar
• Turpeinen U, Lehtovirta P, Alfthan H, Stenman U-H. Interference by human anti-mouse antibodies in CA 125 assay after immunoscintigraphy: anti-idiotypic antibodies not neutralized by mouse IgG but removed by chromatography. Clin Chem 1990; 36: 1333–8
   PubMed Web of Science ®Google Scholar
• Buccheri G, Biggi A, Ferrigno D, et al. Imaging lung cancer by scintigraphy with indium 111-labeled F(ab')2 fragments of the anticarcino-embryonic antigen monoclonal antibody F023C5. Cancer 1990; 70: 749–59
   Web of Science ®Google Scholar
• Kairemo K JA, Aronen H J., Liewendahl K, et al. Radioimmunoimaging of non-small cell lung cancer with 111in and 99mTc-labelled monoclonal anti-CEA antibodies. Acta Oncol 1993; 32: 771–8
   PubMed Web of Science ®Google Scholar
• Endo K, Kamma H, Ogata T. Radiolocahzation of xenografted human lung cancer with monoclonal antibody 8 in nude mice. Cancer Res 1987; 47: 5427–32
   PubMedGoogle Scholar
• Dazord L, Bourel D, Martin A, et al. A monoclonal antibody (PO 66) directed against human lung squamous cell carcinoma. Immunolocaliza-tion of tumour xenografts in nude mice. Cancer Immunol Immunother 1987; 24: 263–8
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Chen F A., Takita H, Bankert R B. Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp 160 by 125I-labeled anti-gp 160 monoclonal antibody. Cancer Res 1988; 48: 2768–73
   PubMed Web of Science ®Google Scholar
• Waibel R, O'Hara C J., Smith A, Stahel R A. Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA 20. Cancer Res 1988; 48: 4318–25
   PubMed Web of Science ®Google Scholar
• Mulshine J L., Keenan A M., Carrasquillo J A., et al. Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Cancer Res 1987; 47: 3572–6
   PubMed Web of Science ®Google Scholar
• Balaban E P., Walker B S., Cox J V., et al. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard methods. Clin Nucl Med 1992; 17: 439–45
   PubMed Web of Science ®Google Scholar
• Divgi C R., Welt S, Kris M, et al. Phase I and imaging trial of indium-111 labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991; 83: 97–104
   PubMed Web of Science ®Google Scholar
• Friedman S, Sullivan K, Salk D, et al. Staging non-small cell carcinoma of the lung using technetium labeled monoclonal antibodies. Hematol Oncol Clin North Am 1990; 4: 1069–78
   PubMed Web of Science ®Google Scholar
• Krishnamurty S, Morris J F., Antonovich R, et al. Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy. Cancer 1990; 65: 458–65
   PubMed Web of Science ®Google Scholar
• Stein R, Goldenberg D M. Prospects of the management of non-small cell carcinoma of the lung with monoclonal antibodies. Chest 1991; 99: 1466–76
   PubMed Web of Science ®Google Scholar
• Salk D. the Multicentre Study Group. Technetium-labeled monoclonal antibodies for imaging metastatic melanoma: results of a multicenter clinical study. Semin Oncol 1988; 15: 608–18
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Kairento A-L, Pyrhönen S, et al. Localization of melanoma with radiolabeled monoclonal antibody fragments and iodo-amphetamine. Eur J Nucl Med 1986; 12: 359–362
   PubMedGoogle Scholar
• Bomanji J, Hungerford J L., Granowska M, Britton K E. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. Br J Ophthalmol 1987; 71: 651–8
   PubMed Web of Science ®Google Scholar
• Scheidauer K, Markl A, Leinsinger M G., et al. Immunoscintigraphy in intraocular malignant melanoma. Nucl Med Commun 1988; 9: 669–79
   PubMed Web of Science ®Google Scholar
• Fairweather D S., Bradwell A R., Watson-James S F., Dykes P W., Chandler S, Hoffenberg R. Detection of thyroid tumors using radiolabeled anti-thyroglobulin. Clin Endocrinol 1983; 18: 563–70
   PubMed Web of Science ®Google Scholar
• Berche C, Mach J-P, Lumbroso J-D, et al. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen. Br Med J 1982; 285: 1447–51
   PubMed Web of Science ®Google Scholar
• Edington H D., Watson C G., Levine G, et al. Radioimmunodetection of metastatic medullary carcinoma of the thyroid gland using indium-111-labeled monoclonal antibody to CES. Surgery 1988; 104: 1004–10
   PubMed Web of Science ®Google Scholar
• Hammarström S, Shively J E., Paxton R J., et al. Antigenic sites in carcinoembryonic antigen. Cancer Res 1989; 49: 4852–8
   PubMed Web of Science ®Google Scholar
• Vuillez J-P, Peltier P, Caravel J-P, Chetanneau A, Saccavini J-C, Chatal J-F. Immunoscintigraphy using 111I-labeled F(ab')2 fragments of anti-carcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. J Clin Endocrinol Metab 1992; 74: 157–63
   PubMed Web of Science ®Google Scholar
• O'Byrne K J., Hamilton D, Robinson I, Sweeney E, Freyne P J., Cullen M J. Imaging of medullary carcinoma of the thyroid using 111In-labeled anti-CEA monoclonal antibody. Nucl Med Commun 1992; 13: 142–8
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Välimäki M, Taavitsainen M. Localization of hepatic metastases by radio-labelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma. Eur J Nucl Med 1993; 20: 551–4
   PubMedGoogle Scholar
• Gautvik K M., Svindahl K, Skretting A, et al. Uptake and localization 131I-labeled anti-calcitonin immunoglobulins in rat medullary thyroid carcinoma tissue. Cancer 1982; 50: 1107–14
   PubMed Web of Science ®Google Scholar
• Manil L, Boudet F, Motte P, et al. Positive anti-calcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Cancer Res 1989; 49: 5480–5
   PubMed Web of Science ®Google Scholar
• Hakalahti L, Vihko P. Purification of monoclonal antibodies raised against prostate-specific acid phosphatase for use in vitro in radioimaging of prostatic cancer. J Immunol Methods 1989; 117: 131–6
   PubMed Web of Science ®Google Scholar
• Larson A, Arnberg H, Maripuu E, Nilsson S. Radioimmunodetection of prostatic cancer with 1251-labelled antibody against prostatic specific antigen. Scand J Urol Nephrol 1988; 110(Suppl)149–53
   Google Scholar
• Bazinet M, Cote R J., Cordon-Cardo C, Myc A, Fair W R., Old L J. Immunohistochemical characterization of two monoclonal antibodies. P25.48 and P25.91, which define a new prostate-specific antigen. Cancer Res 1988; 48: 6938–42
   PubMedGoogle Scholar
• Eklöv S, Larson A, Björk P, Nilsson S. The expression of estramustine-binding protein in the human prostatic cancer cell line DU 145 is not androgen dependent. Scand J Urol Nephrol 1992; 26: 119–25
   PubMed Web of Science ®Google Scholar
• Raynor R H., Hazra T A., Moncure C W., Mohana-kumar T. Biochemical nature of the prostate-assocated antigen identified by the monoclonal antibody, KR-P8. Prostate 1986; 9: 21–31
   PubMed Web of Science ®Google Scholar
• Horoszewicz J S., Kawinski E, Murphy G P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987; 7: 927–35
   PubMed Web of Science ®Google Scholar
• Kim Y D., Robinson D Y., Manderino G L., Tribby I I., Tomita J T. Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen. Cancer Res 1989; 49: 2379–82
   PubMed Web of Science ®Google Scholar
• Webb K S., Paulson D F., Parks S F., Tuck F L., Walther P J., Ware J L. Characterization of prostate-tissue-directed monoclonal antibody, alpha-Pro 13. Cancer Immunol Immunother 1984; 7: 7–17
   Google Scholar
• Wang M C., Killian C S., Lee C L., Chu T M. Monoclonal antibody assays for prostatic tumor. Immunol Ser 1988; 39: 195–219
   Google Scholar
• Demura T, Kuzumaki N, Oda A, Fujita H, Ishi-bashi T, Koyanagi T. Establishment and characterization of monoclonal antibody against androgen receptor. J Steroid Biochem. 1989; 33: 845–51
   PubMedGoogle Scholar
• Lindgren J, Pak K Y., Ernst C, Rovera G, Steplewski Z, Koprowski H. Shared antigens of human prostate cancer cell lines as defined by monoclonal antibodies. Hybridoma 1985; 4: 37–45
   PubMedGoogle Scholar
• Leroy M, Teillac P, Rain J D., Saccavini J C., LeDuc A, Najean Y. Radioimmunodetection of lymph node invasion in prostatic cancer The use of iodine 123 (123I-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragment in vivo. Cancer 1989; 64: 1–5
   PubMed Web of Science ®Google Scholar
• Abdel-Nabi H H., Ortman-Nabi J A., See W, et al. Clinical experience with intralymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma. Eur J Nucl Med 1990; 16: 149–156
   PubMedGoogle Scholar
• Babaian R J., Murray J L., Lamki L M., et al. Radio-immunological imaging of mestastatic prostatic cancer with 111Indium-labelled monoclonal antibody PAY 276. J Urol 1987; 137: 439–43
   PubMed Web of Science ®Google Scholar
• Halpern S E., Haindl W, Beauregard J, et al. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection. Radiology 1988; 168: 529–36
   PubMed Web of Science ®Google Scholar
• Meyers F J., DeNardo S J., Macey D, White R D., Unger M. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate 1989; 14: 209–20
   PubMed Web of Science ®Google Scholar
• Ahonen A, Kairemo K, Karnani P, et al. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase. Acta Oncol 1993; 32: 723–7
   PubMed Web of Science ®Google Scholar
• Tranter R MD, Fairweather D S., Bradwell A R., Dykes P W., Watson-James S, Chandler S. The detection of squamous cell tumors of the head and neck using radiolabeled antibodies. J Laryngol Otol 1984; 98: 71–4
   PubMed Web of Science ®Google Scholar
• Soo K C., Ward M, Roberts K R., et al. Radio-immunoscintigraphy of squamous carcinomas of the head and neck. Head Neck Surg 1987; 9: 349–52
   PubMedGoogle Scholar
• van Dongen G AMS, Leverstein H, Roos J C., et al. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2. Cancer Res 1992; 52: 2569–74
   PubMed Web of Science ®Google Scholar
• Baum R P., Adams S, Kiefer J, et al. A novel 99mTc labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 1993; 32: 747–51
   PubMed Web of Science ®Google Scholar
• Abdel-Nabi H, Hinkle G H., Falko J M., Kelly D, Olsen J O., Martin E W. Iodine-131 labelled anti-CEA antibodies uptake by Hürthle cell carcinoma. Clin Nucl Med 1985; 10: 713–5
   PubMed Web of Science ®Google Scholar
• Kairemo K JA, Hopsu E VM, Melartin E J., Heikkilä P S. Imaging of a parapharyngeal hemangiopericytoma. Radioimmunoscintigraphy (SPECT) with indium-111-labeled anti-CEA antibody, and comparison to digital subtraction angiography, computed tomography and immunohisto-chemistry. Cancer 1992; 67: 61–6
   Web of Science ®Google Scholar
• Kairemo K JA, Hopsu E VM. Radioimmunodetection of chemodectoma by In-111 labeled anti-CEA antibody. Case report and review of the literature. Clin Nucl Med 1990; 15: 900–3
   PubMed Web of Science ®Google Scholar
• Kairemo K JA, Hopsu E VM. Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies. Laryngoscope 1990; 100: 1077–82
   PubMed Web of Science ®Google Scholar
• Kairemo K JA, Hopsu E VM. Diagnosis of tumors of the parotid gland with anti-CEA immunoscinti-graphy. Am J Roentgenol 1990; 154: 1259–62
   PubMed Web of Science ®Google Scholar
• Timon C I., McShane D, Hamilton D, Walsh M A. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project. J Otolaryngol 1991; 20: 283–7
   PubMedGoogle Scholar
• Larson S M. Radiolabeled monoclonal antitumor antibodies in diagnosis and therapy. J Nucl Med 1985; 26: 538–45
   PubMed Web of Science ®Google Scholar
• Farrands P A., Perkins A C., Sully L, et al. Localisation of human osteosarcoma by an anti-tumor monoclonal antibody. J Bone Joint Surg 1983; 65B: 638–40
   Google Scholar
• Bruland Ø, Aas M, Fodstad Ø, et al. The potential usefulness of two novel anti-sarcoma monoclonal antibodies for immuno-scintigraphy of human bone sarcomas. Abstracts of The Fifth International Conference of Monoclonal Antibody Immunoconjugates for Cancer, San Diego, CA, March, 15–17, 1990; 83, USA
   Google Scholar
• Greager J A., Brown J M., Pavel D G., Garcia J L., Blend M, Gupta T KD. Localization of human sarcoma with radiolabeled monoclonal antibody. A preliminary study. Cancer Immunol Immuno-ther 1986; 23: 148–54
   PubMed Web of Science ®Google Scholar
• Kairemo K JA, Wiklund T A., Liewendahl K, et al. Imaging of soft tissue-sarcomas with In-111 -labeled monoclonal antimyosin antibody fragments. J Nucl Med 1990; 31: 23–31
   PubMed Web of Science ®Google Scholar
• Cox P H., Verweij J, Pillay M, Stoter G, Schonfeld D. Indium111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma. Eur J Nucl Med 1988; 14: 50–2
   PubMedGoogle Scholar
• Hoefnagel C A., de Kraker J, Voute P A., Behrendt H. Tumor imaging of radiolabeled fragments of monoclonal antimyosin antibody. J Nucl Med 1988; 29: 791
   Web of Science ®Google Scholar
• Makiya R, Stigbrand T. Placental alkaline phosphatase as the placental IgG receptor. Clin Chem 1992; 38: 2543–5
   PubMed Web of Science ®Google Scholar
• Barsky S H., Baker A, Siegal G P., Togo S, Liotta L A. Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. A, J Surg Pathol 1983; 7: 667–77
   PubMed Web of Science ®Google Scholar
• Wahl R L., Kimmel K A., Beierwaltes W H., Carey T E. Radioimmunodiagnosis of human-derived squamous cell carcinoma. Hybridoma 1987; 6: 111–9
   PubMedGoogle Scholar
• Wahl R L., Liebert M, Headington J, et al. Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail. Cancer Res 1990; 50: 941S–8S
   Web of Science ®Google Scholar
• Ingvar C, Norrgren K, Strand S-E, Brodin T, Jonsson P E., Sjögren H-O. Subcutaneous injection of monoclonal antibody 96.5. Biokinetics in the nude rat heterotransplanted with malignant melanoma. Acta Oncol 1990; 29: 1047–53
   PubMed Web of Science ®Google Scholar
• Frytak S, Creagan E T., Brown M L., Salk D, Nelp W. A technetium-labeled monoclonal antibody for imaging metastatic melanoma. Am J Clin Oncol 1991; 14: 156–61
   PubMed Web of Science ®Google Scholar
• Mulshine J L., Carrasquillo J A., Weinstein J N., et al. Direct intralymphatic injection of radiolabeled 111in-T101 in patients with cutaneous T-cell lymphoma. Cancer Res 1991; 51: 688–95
   PubMed Web of Science ®Google Scholar
• Shah S A., Gallagher B M., Sands H. Lymphoscintigraphy of human colorectal carcinoma mestas-tases in athymic mice by use of radioiodinated B 72.3 monoclonal antibody. J Natl Cancer Inst 1987; 78: 1069–77
   PubMedGoogle Scholar
• Schatten C, Pateisky N, Barrada M, Enzelsberger H, Czerwenka K, Kubista E. Immun-Lymphszintigraphie in der gynäkologischen Onkologie. Gynäkol-Rundschau 1991; 31: 247–9
   PubMedGoogle Scholar
• Larson S M., Pentlow K S., Volkow N D., et al. PET scanning of iodine-124–3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med 1992; 33: 2020–3
   PubMed Web of Science ®Google Scholar
• Kairemo K JA. Positron emission tomography of monoclonal antibodies. Acta Oncol 1993; 32: 825–30
   PubMed Web of Science ®Google Scholar